Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 468
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07545213 | Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis | ||
| NCT07551427 | A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis | ||
| NCT07294261 | Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC | ||
| NCT07107256 | Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps | ||
| NCT06433531 | A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) | ||
| NCT07663331 | A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis | ||
| NCT03743129 | Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029） | ||
| NCT06448273 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects | ||
| NCT05045872 | Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging | ||
| NCT06682169 | Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease | ||
| NCT05493995 | A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. | ||
| NCT06948539 | To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors | ||
| NCT03461627 | Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma | ||
| NCT05849727 | A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis | ||
| NCT06031480 | Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors | ||
| NCT01886053 | A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia | ||
| NCT03457844 | A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3 | ||
| NCT06527144 | A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | ||
| NCT06449859 | A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects | ||
| NCT03601975 | Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma | ||
| NCT05687864 | Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance Imaging | ||
| NCT07794111 | A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects. | ||
| NCT04063683 | Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）. | ||
| NCT05830500 | Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma | ||
| NCT06222944 | Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA | ||
| NCT06672263 | A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia | ||
| NCT02752516 | A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics | ||
| NCT05994365 | Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma | ||
| NCT07043751 | A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors | ||
| NCT04234607 | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) | ||
| NCT03983928 | Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer | ||
| NCT03855384 | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN） | ||
| NCT03750916 | Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer | ||
| NCT07003074 | A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer | ||
| NCT07172126 | Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets | ||
| NCT03890068 | Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma | ||
| NCT05645315 | Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors | ||
| NCT04073550 | Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer | ||
| NCT07314060 | A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis | ||
| NCT07011186 | A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies | ||
| NCT05033587 | Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. | ||
| NCT02029209 | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT04306887 | A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL) | ||
| NCT06452706 | The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer | ||
| NCT04275583 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule | ||
| NCT06931145 | Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer | ||
| NCT06188624 | Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers | ||
| NCT04216082 | A Study of Anlotinib in Subjects With Advanced Malignancy | ||
| NCT07622667 | Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis | ||
| NCT07569757 | Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma |
